Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Case 15 - The spacey, fidgety son with overwhelming sadness
Published online by Cambridge University Press: 19 October 2021
Book contents
- Case Studies: Stahl’s Essential Psychopharmacology
- Case Studies Stahl’s Essential Psychopharmacology
- Copyright page
- Contents
- Introduction
- Contributors
- List of icons
- Abbreviations
- Case 1 Wearing down a diagnosis
- Case 2 The woman who couldn’t handle her lips smacking any longer
- Case 3 The depressed bipolar patient on multiple medications
- Case 4 The agitated patient who finally wasn’t
- Case 5 The George who was not psychotic but anxious and distracted
- Case 6 The man who saw enemies everywhere
- Case 7 The young woman with psychosis complicated by substance use and a history of traumatic brain injury
- Case 8 The woman with worsening psychosis and a mysterious rash
- Case 9 The man without a plan
- Case 10 The anxious depressed woman who couldn’t sit still
- Case 11 The man who thinks it’s the end of the world
- Case 12 Sunny with a chance of depression
- Case 13 A not-so-simple case of anxiety
- Case 14 I’m a woman in a man’s body
- Case 15 The spacey, fidgety son with overwhelming sadness
- Case 16 The man who spent thousands online
- Case 17 The traumatized mother who can’t stop bingeing
- Case 18 The man who couldn’t stop hitting people
- Case 19 Brexpiprazole: “an awakening”
- Case 20 Treatment-resistant depression and opioid dependence
- Case 21 A stiff patient
- Case 22 An adolescent awakening
- Case 23 The peace keeper with a left breast mass
- Case 24 The girl who slept with problems
- Case 25 Not all child’s play: a path to pediatric stability
- Case 26 The young woman who was “nothing but skin and bones”
- Case 27 Could it be both? Comorbid psychiatric diagnoses
- Case 28 Treatment-emergent mania/hypomania in a depressed patient
- Case 29 The border between mood and personality
- Case 30 The student who wanted to go to rehab
- Case 31 The boy who wouldn’t (couldn’t) listen
- Case 32 The patient who went streaking
- Case 33 “Perseverance”
- Case 34 Clozapine (Clozaril) candidate discombobulates compassionate clinicians
- Index of drug names
- Index of case studies
- References
Summary
Pretest self-assessment question (answer at the end of the case)
- Type
- Chapter
- Information
- Case Studies: Stahl's Essential Psychopharmacology , pp. 155 - 170Publisher: Cambridge University PressPrint publication year: 2021
References
American Psychiatric Association. Practice Guideline for the Treatment of Patients with Major Depressive Disorder, 3rd edn. Arlington, VA: American Psychiatric Association, 2010. Available from https://www.guidelinecentral.com/summaries/practice-guideline-for-the-treatment-of-patients-with-major-depressive-disorder-third-edition/Google Scholar
Bangs, ME, Jin, L, Desaiah, D, et al. Hepatic events associated with atomoxetine treatment for attention-deficit hyperactivity disorder. Drug Saf 2012: 31:345–54. https://doi.org/10.2165/00002018-200831040-00008Google Scholar
Birmaher, B, Brent, D, AACAP Work Group on Quality Issues. Practice parameter for the assessment and treatment of children and adolescents with depressive disorders. J Am Acad Child Adolesc Psychiatry 2007; 46:1503–26. https://doi.org/10.1097/chi.0b013e318145ae1cCrossRefGoogle ScholarPubMed
Blankenstein, MA. Reference intervals – ever met a normal person? Ann Clin Biochem 2015; 52:5–6. https://doi.org/10.1177/0004563214561563CrossRefGoogle Scholar
Carandang, C, Jabbal, R, Macbride, A, Elbe, D. A review of escitalopram and citalopram in child and adolescent depression. J Can Acad Child Adolesc Psychiatry 2011; 20:315–24.Google Scholar
Dulcan, MK, Benson, RS. Summary of the practice parameters for the assessment and treatment of children, adolescents, and adults with ADHD. J Am Acad Child Adolesc Psychiatry 1997; 36:1311–17. https://doi.org/10.1097/00004583-199709000-00033CrossRefGoogle ScholarPubMed
Dynamed. Abnormal liver function tests – approach to the patient. 2018. Available from: https://www.dynamed.com/topics/dmp~AN~T316452 (accessed March 26, 2021).Google Scholar
Eli Lilly and Company. Medication Guide: Strattera. Indianapolis, IN: Eli Lilly and Company, 2003. Available from: http://pi.lilly.com/us/strattera-ppi.pdfGoogle Scholar
Felitti, VJ, Anda, RF, Nordenberg, D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults. The Adverse Childhood Experiences (ACE) Study. Am J Prev Med 1998; 14:245–58. https://doi.org/10.1016/s0749-3797(98)00017-8CrossRefGoogle ScholarPubMed
Fugh-Berman, A. Herbal medicinals: selected clinical considerations, focusing on known or potential drug–herb interactions. Arch Intern Medi 1999; 159:1957–9. https://doi.org/10.1001/archinte.159.16.1957Google Scholar
Garland, EJ, Kutcher, S, Virani, A, Elbe, D. Update on the use of SSRIs and SNRIs with children and adolescents in clinical practice. J Can Acad Child Adolesc Psychiatry 2016; 25:4–10.Google Scholar
Hagerman, RJ, Berry-Kravis, E, Hazlett, HC, et al. Fragile X syndrome. Nat Rev Dis Primers, 2017; 3, 17065. https://doi.org/10.1038/nrdp.2017.65CrossRefGoogle ScholarPubMed
Kratochvil, CJ, Newcorn, JH, Arnold, LE, et al. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J Am Acad Child Adolesc Psychiatry, 2005; 44: 915–24. https://doi.org/10.1097/01.chi.0000169012.81536.38CrossRefGoogle ScholarPubMed
March, JS. The Treatment for Adolescents with Depression Study (TADS). Washington, DC: American Academy for Child and Adolescent Psychiatry, 2006. Available from: https://www.aacap.org/aacap/families_and_youth/Resources/Psychiatric_Medication/The_Treatment_for_Adolescents_with_Depression_Study_TADS.aspx (accessed March 26, 2021).Google Scholar
March, J, Silva, S, Vitiello, B. The Treatment for Adolescents with Depression Study (TADS): methods and message at 12 weeks. J Am Acad Child Adolesc Psychiatry 2006; 45:1393–403. https://doi.org/10.1097/01.chi.0000237709.35637.c0CrossRefGoogle ScholarPubMed
Muhle, RA, Reed, HE, Vo, LC, et al. (2017). Clinical diagnostic testing for individuals with developmental disorders. J Am Acad of Child Adolesc Psychiatry 56:910–13. https://doi.org/10.1016/j.jaac.2017.09.418CrossRefGoogle ScholarPubMed
National Institute of Diabetes and Digestive and Kidney Diseases. Atomoxetine. In: LiverTox: Clinical and Research Information on Drug-Induced Liver Injury. Bethesda, MD: National Institute of Diabetes and Digestive and Kidney Diseases, 2012. Available from: https://www.ncbi.nlm.nih.gov/books/NBK548671/Google Scholar
Roberts, EA, Schilsky, ML. Diagnosis and treatment of Wilson disease: an update. Hepatology 2008; 47:2089–111. https://doi.org/10.1002/hep.22261Google Scholar
Rush, AJ, Trivedi, MH, Wisniewski, SR, et al. Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report. Am J Psychiatry 2006; 163:1905–17. https://doi.org/10.1176/ajp.2006.163.11.1905Google Scholar
Siegel, M, McGuire, K, Veenstra-VanderWeele, J, et al. Practice parameter for the assessment and treatment of psychiatric disorders in children and adolescents with intellectual disability (intellectual developmental disorder). J Am Acad Child Adolesc Psychiatry 2019; 59:468–96. https://doi.org/10.1016/j.jaac.2019.11.018Google ScholarPubMed
Stahl, SM. Stahl’s Essential Psychopharmacology: Prescriber’s Guide, 6th edn. Cambridge, UK: Cambridge University Press, 2017.Google Scholar
Varigonda, AL, Jakubovski, E, Taylor, MJ, et al. Systematic review and meta-analysis: early treatment responses of selective serotonin reuptake inhibitors in pediatric major depressive disorder. J Am Acad of Child Adolesc Psychiatry 2015; 54:557–64. https://doi.org/10.1016/j.jaac.2015.05.004Google Scholar
Whyte, MP. Physiological role of alkaline phosphatase explored in hypophosphatasia. Ann N Y Acad Sci 2010; 1192: 190–200. https://doi.org/10.1111/j.1749-6632.2010.05387.xCrossRefGoogle ScholarPubMed